Publications Authored by Pathology Faculty Members
(Years: 2008 – 2009)
updated September 2009
Jorge Benach, Ph.D.
LaRocca, TA and JL Benach. 2008. The important and diverse roles of antibodies in the host response to Borrelia infections. Curr Top Microbiol Immunology. 319:63-103.
Larocca T, LI Katona, DG Thanassi, JL Benach. 2008. The bactericidal function of an antibody to relapsing fever Borrelia resides in its variable region. J. Immunol.180:6222 – 6228.
Forestal CA, H Gil, M Monfett, CE Noah, GJ Platz, DG Thanassi, JL Benach, MB Furie. 2008. A conserved and immunodominant lipoprotein of Francisella tularensis is proinflammatory but not essential for virulence. Microbial Pathogenesis 44:512-523..
Chakraborty S, M Monfett M, TM Maier, JL Benach, DW Frank, DG Thanassi: 2008. Type IV pili in Francisella tularensis: roles of pilF and pilT in fiber assembly,host cell adherence and virulence. Infection lmmunity 76: 2852 – 2861.
Ivanov, MI, BL Noel, R Rampersaud, P Mena, JL Benach, JB Bliska. 2008. Vaccination of mice with a Yop translocon complex elicits antibodies that are protective against infection with F1- Yersinia pestis. Infect. Immun. 76: 5181 – 5190.
Grellier P, JL Benach, M Labaied, S Charneau, H Gil, G Monsalve, R Alfonso, L Sawyer L, L Lin, M Steiert, K Dupuis. 2008. Photochemical inactivation with amotosalen and long-wavelength ultraviolet light of Plasmodium and Babesia in platelet and plasma components.Transfusion 48(8):1676-84.
Savitt, AG, P Mena, JL Benach. 2009. Francisella tularensis infection-derived monoclonal antibodies provide detection, protection and therapy. Clinical Vaccine Immunology 16: 414-422..
Malkiel. S, CJ Kuhlow, P Mena, JL Benach. 2009. The loss and gain of marginal zone and peritoneal B cells is different in response to relapsing fever and Lyme disease Borrelia. J Immunology 182: 498-506.
LaRocca TJ, D Holthausen, JL Benach. 2009. The Bactericidal Effect of a Complement-Independent Antibody is Osmolytic and Specific to Borrelia. PNAS. In Press.
Rasmussen JW, P Mena, MB Furie, DG Thanassi, JL Benach. 2009. Myeloid-derived suppressor cells are prominent in the splenic response to Francisella tularensis infection. In review.
Ann Berger Zaslav, Ph.D.
Ovotesticuar Disorder of Sexual Development (True Hermaphroditism). 2009. Urology 73: 293-296.
Youjun Hu, Ann-Leslie Zaslav, et al. Myelofibrosis Involving Lymph Node: Identification of a Novel Cytogenetic Abnormality in a Mimicker of a Mesenchymal Neoplasm. Journal of Hematopathology, 2009.
Jay Bock, M.D., Ph.D.
A. J. Singer, P. Viccellio, H. C. Thode Jr., J. L. Bock, M. C. Henry. Introduction of a stat laboratory reduces emergency department length of stay. Academic Emergency Medicine, 2008; 15:324-8.
J. L. Bock, A. J. Singer, H. C. Thode Jr. Comparison of Emergency Department patient classification by point-of-care and central laboratory methods for cardiac troponin I. American Journal of Clinical Pathology, 2008; 130:132-5
Richard Bronson, M.D.
Shetty J, Bronson R, Herr JC. Human sperm protein encyclopedia and alloantigen index: Mining novel alloantigens of acrosome and tail using sera from ASA positive infertile patients and vasectomized men. J. Reprod. Immunol. 77: 23 -21, 2008
Veuate C, Furlong LI, Bronson R, Harris JD, Vazquez-Levin MH. Antiacrosin antibodies. I. Incidence in female patients consulting for infertility and effect upon proacroin/acrosin functions. Fertil. Steril. Epub April 28, 2008.
Bronson, RA. Immune Aspects of Infertility. Global Library of Women’s Medicine, Edited by John Schiarra, 2008.
Bronson, R.A. The Best of Bellevue Literary Review, Reviews & Reflections, The Pharos, (Autumn) 71: 244-246, 2008.
Imperfect Knowledge, CMAJ 179, 563, 2008
To His Violin, CMAJ 179, 936, 2008
Father’s Day, Med. J. Australia, 189, 288, 2008
What Kind of Guy? The Pharos, Winter, 2009
Bronson, R.A. Antisperm Antibodies: Their Role in Male Infertility, in Male Infertility -Surgical & Medical Management, Eds. Marc Goldstein & Peter N. Schlegel, Cambridge University Press, in press 2009.
Jian Cao
Dufour A, Sampson NS, Zucker S, Cao J. Role of the hemopexin domain of matrix metalloproteinases in cell migration. J Cell Physiol. 2008 Dec;217(3):643-51. PubMed PMID: 18636552; PubMed Central PMCID: PMC2574584.
Cao J, Chiarelli C, Richman O, Zarrabi K, Kozarekar P, Zucker S. Membrane type 1 matrix metalloproteinase induces epithelial-to-mesenchymal transition in prostate cancer. J Biol Chem. 2008 Mar 7;283(10):6232-40. Epub 2008 Jan 3. PubMed PMID: 18174174.
Martha Furie, Ph.D.
Forestal C.A., H. Gil, M. Monfett, C.E. Noah, G.J. Platz, D.G. Thanassi, J.L. Benach, and M.B. Furie (2008) A conserved and immunodominant lipoprotein of Francisella tularensis is proinflammatory but not essential for virulence. Microb. Pathog. 44: 512-523.
Bakshi, C. S., M. Malik, M. Mahawar, G. S. Kirimanjeswara, K. R. O. Hazlett, L. E. Palmer, M. B. Furie, R. Singh, J. A. Melendez, T. J. Sellati, and D. W. Metzger (2008) An improved vaccine for prevention of respiratory tularemia caused by Francisella tularensis SchuS4 strain. Vaccine 26: 5276-5288.
Dennis Galanakis, M.D.
Wolfgang Miesbach1, Dennis Galanakis, Inge Scharrer. Treatment of patients with dysfibrinogenemia and a history of abortions during pregnancy. Blood Coagulation & Fibrinolysis, in press, 2009
Marc Golightly, Ph.D.
Kanokporn Noy Rithidech, Marc Golightly, Elbert Whorton. Analysis of Cell Cycle in Mouse Bone Marrow Cells following Acute in vivo Exposure to 56Fe Ions. Journal of Radiation Research 49:437-443, 2008
Lourdes Aguayo-Figueroa, Marc G. Golightly, Youjun Hu, Harris Cohen, and Thomas Wilson. Cytology and Flow Cytometry to identify Ectopic Thymic tissue masquerading as a Thyroid Nodule in two children. 2009. Thyroid 19:403-406.
Eric D. Spitzer, Silvia G. Spitzer, and Marc G. Golightly. (2008). “Molecular and Serologic Methods for Diagnosis of Encephalitis” in Encephalitis: Diagnosis and Treatment. ed J Halperin. Pg 81-100. Marcel Dekker, Taylor & Francis Books, Inc. New York, NY.
Marc Golightly, Candace Golightly, and Christine Stevens, "Serological Diagnosis of Spirochete diseases", in Clinical Immunology and Serology: A laboratory perspective, 3rd ed, Christine Stevens ed, FA David, Phil, Pa (in press-release date 8/2009).
Youjun Hu, Ann-Leslie Zaslav, Neetu Radhakrishnan, Marc Golightly, Colette Pameijer. Myelofibrosis Involving Lymph Node: Identification of a Novel Cytogenetic Abnormality in a Mimicker of a Mesenchymal Neoplasm, Journal of Hematopathology, 2009.
Eli Hatchwell, MA MB BChir (Cantab) BA (OU) DPhil (Oxon) [MD PhD]
Toriello HV, Hatchwell E. (2008) Toriello-Carey syndrome phenotype and chromosome anomalies. Am J Med Genet A. Jan 1;146(1):116.
Roohi J, Montagna C, Tegay DH, Palmer LE, Devincent C, Pomeroy JC, Christian SL, Nowak N, Hatchwell E. Disruption of Contactin 4 in 3 Subjects with Autism Spectrum Disorder. J Med Genet. 2008 Mar 18. [Epub ahead of print]. This paper was widely reported in the media as a significant advance in Autism research (e.g., http://www.reuters.com/article/healthNews/idUSN1822054420080318).
Roohi J, Tegay DH, Pomeroy JC, Burkett S, Stone G, Stanyon R, Hatchwell E. A de novo Apparently Balanced Translocation [46,XY,t(2;9)(p13;p24)] Interrupting RAB11FIP5 Identifies a New Candidate Gene for Autism Spectrum Disorder. Am J Med Genet B Neuropsychiatr Genet. 2008 Apr 2. [Epub ahead of print].
Christian SL, Brune CW, Sudi J, Kumar RA, Liu S, Karamohamed S, Badner JA, Matsui S, Conroy J, McQuaid D, Gergel J, Hatchwell E, Gilliam TC, Gershon ES, Nowak NJ, Dobyns WB, Cookjr EH. Novel Submicroscopic Chromosomal Abnormalities Detected in Autism Spectrum Disorder. Biol Psychiatry. 2008 Mar 26. [Epub ahead of print].
Roohi J, Cammer M, Montagna C, Hatchwell E. An Improved Method for Generating BAC DNA Suitable for FISH. Cytogenet Genome Res. 2008;121(1):7-9. Epub 2008 May 7.
Eli Hatchwell. ATROUBLESHOOTING GUIDE: EXPERTS SHARE THEIR ADVICE ON PERFORMING ARRAYCOMPARATIVE GENOMIC HYBRIDIZATION GENOME TECHNOLOGY. Array CGH Tech Guide. Genome Technology, September 2008.
Zhi J, Hatchwell E. Human MLPA Probe Design (H-MAPD): a probe design tool for both electrophoresis-based and bead-coupled human multiplex ligation-dependent probe amplification assays. BMC Genomics. 2008 Sep 10;9:407. This paper presents a method for MLPA design, which is notoriously difficult and often considered a major stumbling block for new assays. It is available for use by academics at: http://genomics01.arcan.stonybrook.edu/mlpa/cgi-bin/mlpa.cgi. This paper has been cited as highly accessed by BioMed Central.
Gadow KD, Roohi J, DeVincent CJ, Hatchwell E. Association of ADHD, tics, and anxiety with dopamine transporter (DAT1) genotype in autism spectrum disorder. J Child Psychol Psychiatry. 2008 Dec;49(12):1331-8.
Roohi J, Devincent CJ, Hatchwell E, Gadow KD. Association of a Monoamine Oxidase-A Gene Promoter Polymorphism With ADHD and Anxiety in Boys With Autism Spectrum Disorder. J Autism Dev Disord. 2009 Jan;39(1):67-74. Epub 2008 Jun 20
Hajcak G, Castille C, Olvet DM, Dunning JP, Roohi J, Hatchwell E. Genetic variation in brain-derived neurotrophic factor and human fear conditioning. Genes Brain Behav. 2009 Feb;8(1):80-5.
Tegay DH, Chan KK, Leung L, Wang C, Burkett S, Stone G, Stanyon R, Toriello HV, Hatchwell E. Toriello-Carey syndrome in a patient with a de novo balanced translocation [46,XY,t(2;14)(q33;q22)] interrupting SATB2. Clin Genet. 2009 Mar;75(3):259-64.
Oda M, Glass JL, Thompson RF, Mo Y, Olivier EN, Figueroa ME, Selzer RR, Richmond TA, Zhang X, Dannenberg L, Green RD, Melnick A, Hatchwell E, Bouhassira EE, Verma A, Suzuki M, Greally JM. High-resolution genome-wide cytosine methylation profiling with simultaneous copy number analysis and optimization for limited cell numbers. Nucleic Acids Res. 2009 Apr 22. [Epub ahead of print]
Jingfang Ju, Ph.D.
Phenotypic subpopulations of metastatic colon cancer stem cells: genomic analysis. Botchkina IL, Rowehl RA, Rivadeneira DE, Karpeh MS Jr, Crawford H, Dufour A, Ju J, Wang Y, Leyfman Y, Botchkina GI.
Cancer Genomics Proteomics. 2009 Jan-Feb;6(1):19-29.
Nmi (N-Myc interactor) inhibits Wnt/beta-catenin signaling and retards tumor growth. Fillmore RA, Mitra A, Xi Y, Ju J, Scammell J, Shevde LA, Samant RS.
Int J Cancer. 2009 Jan 21;125(3):556-564. [Epub ahead of print]
Genomic analysis of prostate cancer stem cells isolated from a highly metastatic cell line. Rowehl RA, Crawford H, Dufour A, Ju J, Botchkina GI. Cancer Genomics Proteomics. 2008 Nov-Dec;5(6):301-10.
Reduction of Orc6 expression sensitizes human colon cancer cells to 5-fluorouracil and cisplatin. Gavin EJ, Song B, Wang Y, Xi Y, Ju J. PLoS ONE. 2008;3(12):e4054. Epub 2008 Dec 29.
miR-192 Regulates dihydrofolate reductase and cellular proliferation through the p53-microRNA circuit. Song B, Wang Y, Kudo K, Gavin EJ, Xi Y, Ju J. Clin Cancer Res. 2008 Dec 15;14(24):8080-6.
The impact of genomics in understanding human melanoma progression and metastasis. Ren S, Liu S, Howell P Jr, Xi Y, Enkemann SA, Ju J, Riker AI. Cancer Control. 2008 Jul;15(3):202-15. Review.
The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis. Riker AI, Enkemann SA, Fodstad O, Liu S, Ren S, Morris C, Xi Y, Howell P, Metge B, Samant RS, Shevde LA, Li W, Eschrich S, Daud A, Ju J, Matta J. BMC Med Genomics. 2008 Apr 28;1:13.
Growth of cancer cell lines under stem cell-like conditions has the potential to unveil therapeutic targets. Rappa G, Mercapide J, Anzanello F, Prasmickaite L, Xi Y, Ju J, Fodstad O, Lorico A. Exp Cell Res. 2008 Jun 10;314(10):2110-22. Epub 2008 Mar 20.
CDH11 expression is associated with survival in patients with osteosarcoma. Nakajima G, Patino-Garcia A, Bruheim S, Xi Y, San Julian M, Lecanda F, Sierrasesumaga L, Müller C, Fodstad O, Ju J. Cancer Genomics Proteomics. 2008 Jan-Feb;5(1):37-42.
Global comparative gene expression analysis of melanoma patient samples, derived cell lines and corresponding tumor xenografts. Xi Y, Riker A, Shevde-Samant L, Samant R, Morris C, Gavin E, Fodstad O, Ju J. Cancer Genomics Proteomics. 2008 Jan-Feb;5(1):1-35.
Large isoform of MRJ (DNAJB6) reduces malignant activity of breast cancer. Mitra A, Fillmore RA, Metge BJ, Rajesh M, Xi Y, King J, Ju J, Pannell L, Shevde LA, Samant RS. Breast Cancer Res. 2008;10(2):R22. Epub 2008 Mar 7.
Validation of biomarkers associated with 5-fluorouracil and thymidylate synthase in colorectal cancer. Xi Y, Formentini A, Nakajima G, Kornmann M, Ju J. Oncol Rep. 2008 Jan;19(1):257-62.
Toward the development of chemoprevention agents (III): synthesis and anti-inflammatory activities of a new class of 5-glycylamino-2-substituted-phenyl-1,3-dioxacycloalkanes. Bi L, Zhao M, Gu K, Wang C, Ju J, Peng S. Bioorg Med Chem. 2008 Feb 15;16(4):1764-74. Epub 2007 Nov 12
Antonius Koller, Ph.D.
Worby,C.A., S. Mattoo, R. P. Kruger, L. B. Corbeil, A. Koller, J. C. Mendez, B. Zekarias, C. Lazar and J. E. Dixon. 2009. The Fic Domain: Regulation of cell signaling by adenylylation. Mol. Cell, 34:93-103.
Sharon Liang, M.D., Ph.D.
Fadare O, Orejudos MP, Jain R, Mariappan MR, Hecht JL, Renshaw IL, Hileeto D, Wang, S, Ghofrani M, Liang SX. A comparative analysis of lymphatic vessel density in ovarian serous tumors of low malignant potential (borderline tumors) with and without lymph node involvement. Int J Gynecol Pathol. 2008, Oct;27(4):483-90.
Fadare O and Liang SX. Epithelioid smooth muscle tumors of the uterus do not express CD1a: a potential immunohistochemical adjunct in their distinction from uterine PEComas. Annals of Diagn Pathol. 2008, 12:401-5. (Epub 2008 Jul 7)
Simon RA, P. di Sant’Agnese, Xu H, Yao JL, Yang Q, Bourne PA, Liang S, Liu J, Weit J, Cheng L, Oh WK and Huang J, CD44 Expression is a Feature of Prostatic Small Cell Carcinoma and Distinguishes it from its Mimickers. Human Pathol. 2009, 40(2): 252-8. (Epub 2008 Oct 5, 2008)
Zhang X, Liang SX, Jia L, Chen N, Fadare O, Schwartz PE, Kong B, and Zheng W, Molecular Identification of “Latent Precancers” for Endometrial Serous Carcinoma in Benign Appearing Endometrium, Am J Pathol. 2009, 174(6):2000-6. (Epub 2009 May 12)
Ken Marcu, Ph.D.
Olivotto, E., Borzi', R.M., Vitellozzi, R., Pagani, S., Facchini, A., Battistelli, M., Penzo, M., Li, X., Flamigni, F., Li, J., Falcieri, E., Facchini, A., and Marcu, K.B. (2008) Differential requirements for IKKalpha and IKKbeta in the differentiation of primary human osteoarthritic chondrocytes. Arthritis and Rheumatism 58: 227-239.
Penzo, M., Massa, P.E., Olivotto, Bianchi. F., Borzi, R.M., Hanidu, A., Li, X., Li. J. and Marcu, K.B. (2009). Sustained NF-kB activation produces a short-term cell proliferation block in conjunction with repressing effectors of cell cycle progression controlled by E2F or FoxM1. J. Cellular Physiology 218: 215-227.
Goldring, M.B. and Marcu, K.B. (2009). Cartilage homeostasis in health and rheumatic diseases. Arthritis Research & Therapy 11 224-239.
Giovannini, C., Gramantieri, L.,Chieco, P., Minguzzi, M., Lago, F., Pianetti, S., Ramazzotti, E., Marcu, K.B. and Bolondi, L. (2009). Selective ablation of Notch3 in HCC enhances doxorubicin's death promoting effect by a P53 dependent mechanism. J. of Hepatology 50: 969-979.
Batsi. C., Markopoulou, S., Kontargiris, E., Charalambous, C. Thomas, C., Christoforidis, S., Kanavaros, P., Constantinou, A.I., Marcu, K.B. and Kolettas, E. (2009). Bcl-2 blocks 2-methoxyestradiol induced leukemia cell apoptosis by a p27Kip1-dependent G1/S cell cycle arrest in conjunction with NF-kB. Biochemical Pharmacology 78: 33-44.
Batsi, C., Markopoulou, A., Vartholomatos, G., Georgiou, I., Kanavaros, P., Gorgoulis, V.C., Marcu, K.B. and Kolettas, K. 2009. Chronic NF-kB activation delays RasV12-induced premature senescence of human fibroblasts by suppressing the DNA damage checkpoint response. Mechanisms of Aging and Development (in press).
Ute Moll, M.D., M.S.
Slade N, Moll UM, Brdar B, Zoric A, Jelakovic B. p53 mutations as fingerprints for aristolochic acid: an environmental carcinogen in endemic (Balkan) nephropathy. Mutat Res. 2009 Apr 26;663(1-2):1-6. Epub 2009 Feb 4. PubMed PMID: 19428366.
Vaseva AV, Marchenko ND, Moll UM. The transcription-independent mitochondrial p53 program is a major contributor to nutlin-induced apoptosis in tumor cells. Cell Cycle. 2009 Jun 1;8(11):1711-9. Epub 2009 Jun 30. PubMed PMID: 19411846.
Blandino G, Moll UM. p63 regulation by microRNAs. Cell Cycle. 2009 May 15;8(10):1466-7. Epub 2009 May 15. PubMed PMID: 19411828.
Galluzzi L, . . . Moll UM, et al. Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes. Cell Death Differ. 2009 Apr 17. [Epub ahead of print] PubMed PMID: 19373242.
Wolff S, Talos F, Palacios G, Beyer U, Dobbelstein M, Moll UM. The alpha/beta carboxy-terminal domains of p63 are required for skin and limb development. New insights from the Brdm2 mouse which is not a complete p63 knockout but expresses p63 gamma-like proteins. Cell Death Differ. 2009 Mar 20. [Epub ahead of print] PubMed PMID: 19300453.
Braun CJ, Zhang X, Savelyeva I, Wolff S, Moll UM, Schepeler T, Ørntoft TF, Andersen CL, Dobbelstein M. p53-Responsive micrornas 192 and 215 are capable of inducing cell cycle arrest. Cancer Res. 2008 Dec 15;68(24):10094-104. PubMed PMID: 19074875.
Vaseva AV, Moll UM. The mitochondrial p53 pathway. Biochim Biophys Acta. 2009 May;1787(5):414-20. Epub 2008 Oct 25. PubMed PMID: 19007744.
Zong WX, Moll U. p53 in autophagy control. Cell Cycle. 2008 Oct;7(19):2947. Epub 2008 Oct 1. PubMed PMID: 18818523.
Palacios G, Crawford HC, Vaseva A, Moll UM. Mitochondrially targeted wild-type p53 induces apoptosis in a solid human tumor xenograft model. Cell Cycle. 2008 Aug 15;7(16):2584-90. Epub 2008 Aug 7. PubMed PMID: 18719383.
Wolff S, Erster S, Palacios G, Moll UM. p53's mitochondrial translocation and MOMP action is independent of Puma and Bax and severely disrupts mitochondrial membrane integrity. Cell Res. 2008 Jul;18(7):733-44. PubMed PMID: 18504456.
Tasdemir E, . . . Moll UM, et al. Regulation of autophagy by cytoplasmic p53. Nat Cell Biol. 2008 Jun;10(6):676-87. Epub 2008 May 4. PubMed PMID: 18454141; PubMed Central PMCID: PMC2676564.
Nemajerova A, Talos F, Moll UM, Petrenko O. Rb function is required for E1A-induced S-phase checkpoint activation. Cell Death Differ. 2008 Sep;15(9):1440-9. Epub 2008 May 2. PubMed PMID: 18451867.
Becker K, Marchenko ND, Palacios G, Moll UM. A role of HAUSP in tumor suppression in a human colon carcinoma xenograft model. Cell Cycle. 2008 May 1;7(9):1205-13. Epub 2008 Feb 11. PubMed PMID: 18418047.
Marabese M, Marchini S, Marrazzo E, Mariani P, Cattaneo D, Fossati R, Compagnoni A, Signorelli M, Moll UM, Codegoni AM, Broggini M. Expression levels of p53 and p73 isoforms in stage I and stage III ovarian cancer. Eur J Cancer. 2008 Jan;44(1):131-41. Epub 2007 Nov 26. PubMed PMID: 18039564.
Palacios G, Talos F, Nemajerova A, Moll UM, Petrenko O. E2F1 plays a direct role in Rb stabilization and p53-independent tumor suppression. Cell Cycle. 2008 Jun 15;7(12):1776-81. Epub 2008 Jun 30. PubMed PMID: 18583939.
Alexei Petrenko, Ph.D.
Palacios G, Talos F, Nemajerova A, Moll UM, Petrenko O. E2F1 plays a direct role in Rb stabilization and p53-independent tumor suppression. Cell Cycle. 2008 Jun 15;7(12):1776-81. Epub 2008 Jun 30.
Nemajerova A, Talos F, Moll UM, Petrenko O. Rb function is required for E1A-induced S-phase checkpoint activation. Cell Death Differ. 2008 Sep;15(9):1440-9. Epub 2008 May 2.
Kanokporn Rithidech, Ph.D.
Rithidech, K.N., W. Supanpaiboon, L. Honikel, E.B. Whorton (2009) In Vivo Induction of micronucleus in mouse blood erythrocytes following exposure to 56Fe ions or 137Cs rays, In Press, Adv Space Res
Rithidech, K.N., L. Honikel, R. Rieger, W. Xie, T. Fischer, S. R. Simon (2009) Protein expression profiles in mouse blood plasma following acute whole body exposure to 137Cs rays, Int. J Radiat. Biol., 85(5):432-447, Apr 7:1-16. [Epub ahead of print],
Rithidech, K.N., Honikel, L., Milazzo, M., Madigan, D., Troxell, R., Krupp, L.B. (2009) Protein expression profiles in pediatrics multiple sclerosis: Potential biomarkers, Mult Scler., 15(4):455-464
Rithidech, K.N., B. Scott (2008) Evidence for radiation hormesis after in vitro exposure of human lymphocytes to low doses of ionizing radiation Dose-Response., 6:252-271
Rithidech, K.N., M. Golightly, E.B. Whorton (2008) Analysis of cell cycle in mouse bone marrow cells following acute in vivo exposure to 56Fe ions, J Radiat. Res., 49:437-4343. E-pub April 9.
Lisa Senzel, M.D., Ph.D.
Chiang, J., Ahmed, T., & Senzel, L. TTP presentation and treatment: the Stony Brook experience. Abstract. J. Clin. Apher. 24:61, 2009.
Senzel, L., Gnatenko, D.V. & Bahou, W.F. The role of proteomics and transcriptomics in the development of antithrombotics. New Therapeutic Agents in Thrombosis and Thrombolysis, Freedman & Loscalzo, eds., 3rd ed., 2009.
Senzel, L., Gnatenko, D.V. & Bahou, W.F. Genomic and proteomic applications in diagnosis of platelet disorders and classification. Sem. Thrombos. Hemost. 34:532-38, 2008.
Kenneth Shroyer, M.D., Ph.D.
N.S. Awadallah, K.R. Shroyer, D.A. Langer, K.C. Torkko, Y.K. Chen, J.S. Bentz, J. Papkoff, W. Liu, R.J. Shah, Detection of B7-H4 (DD-O110) and p53 in pancreatic cancer: potential roles as cytologic diagnostic adjuncts, Pancreas. 36:2008, 200-6.
R.O. Greer, A. Meyers, S.M. Said, K.R. Shroyer. Is p16(INK4a) protein expression in oral ST lesions a reliable precancerous marker? Int J Oral Maxillofac Surg. 2008:840-6.
Ling J., Wiederkher U., Cabiness, S., Shroyer K.R., Robinson J. Application of flow cytometry for biomarker-based cervical cancer cells identification. Cancer Cytopathology 36:2008, 76-84.
E.M. Reno, J.M. Haugen, I.K. Dimitrova, T.A. Jackson, K.R. Shroyer, A.P. Bradford. Analysis of protein kinase C delta (PKCδ) in endometrial tumors. Hum Pathol. 2008:21-9.
J.M. Owens, K.R. Shroyer, T.T. Kingdom. Expression of cyclooxygenase and lipoxygenase enzymes in sinonasal mucosa of cystic fibrosis patients. Arch. Otolaryngol Head Neck Surg. 134: 2008, 825-31.
T. Byers, H. Wolf1, W.A. Franklin, S. Braudrick, D. Merrick, K.R. Shroyer, F.R. Hirsch, C. Zeng, A.E. Barón, P.A. Bunn, Y.E. Miller, T.C. Kennedy. Sputum Cytologic atypia predicts incident lung cancer: Defining a latency and histologic specificity. Cancer Epidemiol Biomarkers Prev 17: 2008, 158-62.
M. Singh, N.S. Spoelstra, A. Jean, E. Howe, K.C. Torkko, H.R. Clark, D.S. Darling, K.R. Shroyer, K.B. Horwitz, R.R. Broaddus, J.K. Richer. ZEB1 expression in type I versus type II endometrial cancers: a marker of aggressive disease. Mod Pathol. 2008 21:912-23.
J.E. Barrera, K.R. Shroyer, S. Said, G. Hoernig, R. Melrose, P.D. Freedman, T.A. Wright, R.O. Greer. Estrogen and progesterone receptor and p53 gene expression in adenoid cystic carcinoma. Head and Neck Pathol. (2008).
B.A. Larsen, A.J. Barker, R. Shandas, N. Serkova, K.R. Shroyer, Conrad R. Stoldt. Controlled aggregation of superparamagnetic iron oxide nanoparticles for the development of molecular magnetic resonance imaging probes. Nanotechnology 2008 19:1-7
W.A. High and K.R. Shroyer. Bowen's Disease. Encyclopedia of Molecular Mechanisms of Diseases. Springer Inc. (2009) In press.
D.D. Dehn, A. Taylor, T.J. Fischer, D.P. Malinowski and K.R. Shroyer. Screening for molecular markers of cervical papillomavirus infection: overview of methods and their clinical implications. Methods in Molecular Biology, Inflammation, and Cancer, vol. 511, Humana Press, New York. Kozlov (ed.) pp. 297-310, 2009.
K.R. Shroyer, S.T. Dunn, Guest Editors. Update on Molecular Diagnostics for the Detection of Human Papillomavirus. Journal of Clinical Virology. 45: 2009, S1.
Thomison, J., Kopecki-Thomas, L, and Shroyer, K.R. Human Papillomavirus: Molecular and Cytologic/Histologic Aspects Related to Cervical Intraepithelial Neoplasia and Carcinoma. Human Pathol. 39:2008, 154-166.
Samarawardana P, Shroyer KR . VTCN1 (V-set domain containing T cell activation inhibitor 1). Atlas Genet Cytogenet Oncol Haematol. February 2008 .URL : http://AtlasGeneticsOncology.org/Genes/
Meenakshi Singh, M.D.
Carneiro C, Hurtubis CA, Singh M and Robinson WA. Desmoid tumors of the right rectus abdominus muscle in postpartum women. Arch Gynecol Obstet. 2008 Nov 20. [Epub ahead of print].
Brooks G, Borges V, Singh M, Rabinovitch R, Finlayson C and Elias A. A perimenopausal woman with a small ER+/HER2+, node negative breast cancer. Oncology (Williston Park) 2008 Oct;22(11):1270-6.
Singh M, Speolstra NS, Jean A, Howe EN, Shroyer KS, Torkko KC, Clark HR, Darling D, Horwitz KB, Broaddus RR and Richer JK. ZEB 1 expression in type I vs type II endometrial cancers: a marker of aggressive disease. Modern Pathology 2008 21(7):912-23, Epub May 16, 2008.
Klopper JP, Berenz A, Hays WR, Sharma V, Pugazhenthi U, Janssen J, Singh M, Bissonnette RP and Haugen BR. In Vivo and Microarray Analysis of the Treatment Effects of a Rexinoid on the Anaplastic Thyroid Carcinoma Cell Line DRO-90. Clinical Cancer Research 2008;14(2), 589-96.
Raina K, Rajamanickam S, Deep G, Singh M, Agarwal R and Agarwal C. Chemopreventive effects of oral gallic acid feeding on tumor growth and progression in TRAMP mice. Mol Cancer Therapeutics 2008;7(5):1258-67. Epub Apr 29, 2008.
Harvell DM, Spoelstra NS, Singh M, Finlayson C, Phang T, Trapp S, Hunter L, Borges VB, Elias A , KB Horwitz and JK Richer. Molecular Signatures of Response to Neoadjuvant Endocrine Therapy for Breast Cancer. Breast Cancer Res Treat. Epub 9 Mar, 2008.
Harvell DM, Richer JK, Singh M, Spoelstra N, Finlayson C, Borges VB, Elias A , and KB Horwitz. Estrogen regulated gene expression in response to neoadjuvant hormone therapy of breast cancers: Tamoxifen agonist effects dominate in the presence of aromatase inhibitor. Breast Cancer Res Treat. Epub Mar 13, 2008).
Denise A Trochesset, D.D.S.
A peripheral giant cell granuloma associated with hyperparathyroidism secondary to end stage renal disease. Choi C., Terzian E., Schneider R., Trochesset, D.A., The Journal of Oral and Maxillofacial Surgery; 66: 1063-1066,2008
Adrianus Van Der Velden, Ph.D.
Kim, S.H., A. Visser, C. Cruijsen, A.W.M. van der Velden, and M. Boes (2008). Recruitment of Rab27a to phagosomes controls microbial antigen cross-presentation by dendritic cells. Infection and Immunity 76:5373-80.
Thomas Zimmerman, D.V.M.
A Novel TGF-Beta Antagonist Speeds Reepithelialization and Reduces Scarring of Partial Thickness Porcine Burns Adam J. Singer, MD,* Shuan S. Huang, PhD,† Jung S. Huang, PhD,† Steve A. McClain, MD,* Alexander Romanov, DVM,* Jean Rooney, BS,* Tom Zimmerman, DVM*, Journal of Burn Care Res 2009; 30:329-334
A Novel TGF-Beta Antagonist Speeds Reepithelialization and Reduces Scarring of Partial Thickness Porcine Burns Adam J. Singer, MD,* Shuan S. Huang, PhD,† Jung S. Huang, PhD,† Steve A. McClain, MD,* Alexander Romanov, DVM,* Jean Rooney, BS,* Tom Zimmerman, DVM* Can J Plast Surg Vol 16 Season 2008
Resonant and notch behavior in intracranial pressure dynamics Laboratory investigation Mark E. Wagshul, Ph.D., Erin J. Kelly, Ph.D.,4 Hui Jing Yu, M.S., Barbara Garlick, Ph.D., Tom Zimme rman, D.V.M., and Michael R. Egnor, M.D. J Neurosurg Pediatrics 3:354-364, 2009
